-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II

Symposia: Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Wei-Ying Jen, MD, FRCPath, MA1*, Elias Jabbour2, Fadi G. Haddad, MD1*, Lewis Nasr1*, Nicholas J. Short, MD1, Marianne Zoghbi1*, Cedric Nasnas1*, Ghayas C. Issa3, Musa Yilmaz, MD1*, Naval Daver, MD1, Naveen Pemmaraju, MD1, Lucia Masarova, MD1, Farhad Ravandi, MD, MBBS1, Nitin Jain, MD1, Wuliamatu Deen3*, Christopher Loiselle, BS3*, Lourdes Waller3*, Glenda Banks3*, Rebecca Garris1* and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX

Shanshan Suo, MD1*, Wen-Juan Yu1*, Ying Lu2*, Jiejing Qian, MD1*, Liping Mao, MD1*, Jin Wang3*, Lijing Shen4*, Bingzong Li, MD, PhD5, Huafeng Wang1*, Wenyuan MAI1*, Wanzhuo Xie1*, Xiaomin Wang6*, Dan Zhao7*, Yuanfang Liu3*, Chuan He5* and Jie Jin1

1Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;, Hangzhou, China
2Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, CHN
3Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
5The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
6Department of Hematology, the First Hospital of Shanxi Medical University, Taiyuan, China
7Department of Hematology, Yuncheng Central Hospital, Yuncheng, China

Ibrahim Aldoss, MD1,2, Jianying Zhang, PhD3*, Marjorie Robbins, PhD, MSc, BSc4*, Vaibhav Agrawal, M.D.2, Ahmed Aribi, MD2*, Hoda Pourhassan, MD5, Paul B. Koller, MD2, Amanda Blackmon, DO, MS2*, Karamjeet S. Sandhu, MD2, Haris Ali, MD2, Brian J. Ball, MD2, Andrew Artz, MD, MS6, Monzr M. Al Malki, MD7, Amandeep Salhotra, MD7, Zhaohui Gu, PhD6, Asucena Leon Beltran3*, Christina Lai3*, Michelle Afkhami3*, Lucy Y. Ghoda, PhD8*, Stephen J. Forman, MD, FACP1,9, Guido Marcucci, MD10, Anthony Stein, MD2 and Vinod Pullarkat, MD11

1Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
2Hematology/HCT, City of Hope National Medical Center, Duarte, CA
3City of Hope National Medical Center, Duarte, CA
4Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
5Hematology/HCT, City of Hope, Duarte, CA
6City of Hope, Duarte, CA
7Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
8Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
9Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
10Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
11Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA

Ibrahim Aldoss, MD1, Josep-Maria Ribera, MD, PhD2, Hagop Kantarjian, MD3, Pau Montesinos, PhD, MD4*, Jessica T. Leonard, MD5, David Gomez-Almaguer, MD6, Maria R. Baer, MD7, Carlo Gambacorti-Passerini, MD8, James McCloskey, MD9, Yosuke Minami, MD, PhD10, Cristina Papayannidis, MD, PhD11*, Vanderson Rocha, MD, PhD, MS12*, Philippe Rousselot, MD, PhD13*, Pankit Vachhani, MD14, Eunice S. Wang, MD15, Meliessa Hennessy, MPH16*, Niti Patel, PhD16*, Alexander Vorog, MD16*, Bingxia Wang, PhD16* and Elias Jabbour17

1City of Hope National Medical Center, Duarte, CA
2ICO Badalona-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain
5Oregon Health and Science University, Portland, OR
6Hospital Universitario, UANL; Dr. José Eleuterio Gonzalez, Monterrey, Mexico
7Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
8University Milano-Bicocca, Monza, Italy
9Hackensack University Medical Center, Hackensack, NJ
10National Cancer Center Hospital East, Kashiwa, Japan
11IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna, Italy
12Instituto do Câncer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil
13Centre Hospitalier de Verailles, UMR1184, University Versailles Paris-Saclay, Versailles, France
14University of Alabama at Birmingham, Birmingham, AL
15Roswell Park Comprehensive Cancer Center, Buffalo, NY
16Takeda Development Center Americas, Inc., Lexington, MA
17University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Eric S. Schafer1, Yueh-Yun Chi, PhD2*, Jemily Malvar, MS3*, Teresa Rushing, PharmD4*, Andrew Doan, MD5*, Holly L. Pacenta, MD6*, Reuven J. Schore, MD7, Richard Sposto8*, Roy Leong4*, Paul S. Gaynon, MD5, Jeffrey E. Rubnitz, MD, PhD9, Julio C. Barredo, MD10, Tamra Slone, MD11*, Melinda Pauly, MD12, Alan S. Wayne, MD4, Deepa Bhojwani, MD13 and Terzah M. Horton, MD, PhD14*

1Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX
2Biostatistics, Children's Hospital of Los Angeles, Los Angeles, CA
3Biostatistics, Children's Hospital Los Angeles, Los Angeles, CA
4Children's Hospital of Los Angeles, Los Angeles, CA
5Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA
6Cook Children's Hospital, Fort Worth, TX
7Pathology, Children's National Medical Center, Washington, DC
8Children's Hospital Los Angeles, Los Angeles, CA
9Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
10Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL
11Univ. of TX, Southwestern, Dallas, TX
12Children’s Healthcare of Atlanta, Atlanta, GA
13Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
14Baylor, Houston, TX

Tamer Othman, MD1, Paul B. Koller, MD2, NI-Chun Tsai, MS3*, Dat Ngo, PharmD4*, Jason Chen5*, Amanda Blackmon, DO, MS2*, Hoda Pourhassan, MD6, Vaibhav Agrawal, M.D.2, Idoroenyi Amanam, MD7, Brian J. Ball, MD2, Salman Otoukesh, MD2, Amandeep Salhotra, MD8, Shukaib Arslan, MD2, Monzr M. Al Malki, MD8, Haris Ali, MD2, Karamjeet S. Sandhu, MD2, Ahmed Aribi, MD2*, Andrew Artz, MD, MS9, Forest Marc Stewart, MD2, Eileen Patricia Smith, MD2, Anthony Stein, MD2, Guido Marcucci, MD2, Ryotaro Nakamura, MD10, Vinod Pullarkat, MD2, Ibrahim Aldoss, MD2 and Matthew Genyeh Mei, MD9*

1City of Hope, San Lorenzo, CA
2Hematology/HCT, City of Hope National Medical Center, Duarte, CA
3Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
4Pharmacy, City of Hope National Medical Center, DUARTE, CA
5Pharmacy, City of Hope, Duarte, CA
6Hematology/HCT, City of Hope, Duarte, CA
7Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
8Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
9City of Hope, Duarte, CA
10Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA

Britta Julia Vormoor, MD1*, Tobias Menne, PhD2*, Joshua Savage, PhD3*, Amit Patel, PhD4*, Anna Castleton5*, Adele Kay Fielding, MBBS, PhD6, Donna Lancaster7*, Anne Louise Latif8*, Nick Morley9*, Geoff Shenton10*, Gareth Veal, PhD11*, Julie Irving12*, Pam Kearns, MBChB, PhD, FRCPC3*, Lucinda Billingham3* and Josef Vormoor, MD PhD13

1Princess Maxima Center for Pediatric Oncology, Utrecht, Utrecht, Netherlands
2Newcastle Upon Tyne NHS Hospitals Foundation Trust, Newcastle, United Kingdom
3Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
4University of Birmingham, Birmingham, United Kingdom
5The Christie Hospital NHS Trust, Manchester, United Kingdom
6UCL Cancer Institute, London, United Kingdom
7Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
8Beatson West of Scotland Cancer Centre, GLASGOW, United Kingdom
9Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
10Great North Children’s Hospital, Newcastle, United Kingdom
11Newcastle University, Newcastle, United Kingdom
12Newcastle University, Newcastle Upon Tyne, ENG, GBR
13Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Marlise R. Luskin, MD1, Shai Shimony, MD2*, Julia Keating, MS3*, Wendy Stock, MD4, Hanno Hock, MD, PhD5, Jacqueline S. Garcia, MD2, Maximilian Stahl, MD6, Ilene Galinksy7*, Rebecca Leonard2*, Howard Weiner8*, Yael Flamand, MS7*, Donna S. Neuberg, ScD3, Richard M Stone, MD7, Anthony G. Letai7, Eric S. Winer, MD7, Marina Y. Konopleva9, Nitin Jain, MD10 and Daniel J. DeAngelo7

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4The University of Chicago Medical Center, Chicago, IL
5Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
6Dana Farber Institute, Boston, MA
7Dana-Farber Cancer Institute, Boston, MA
8University of Chicago, Chicago, IL
9Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
10Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Susan R Rheingold, MD1, Lingyun Ji, PhD2*, Lia Gore, MD3, Xinxin Xu, MS4*, Deepa Bhojwani, MD5, Nirali N. Shah, M.D.6, Elizabeth A. Raetz, MD7, Mignon L. Loh, MD8 and Maureen M. O'Brien, MD9

1Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Population and Public Health Sciences, University of Southern California,, Los Angeles, CA
3Center for Cancer and Blood Disorders, University of Colorado Cancer Center, Aurora, CO
4Children's Oncology Group, Monrovia, CA
5Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
6Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD
7Department of Pediatrics, NYU Langone Health, New York, NY
8Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Seattle, WA
9Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Selina M Luger, MD, FRCPC1, Zhuoxin Sun, PhD2*, Ryan J Mattison, MD3, Elisabeth Paietta, PhD4*, Kathryn G. Roberts, PhD5*, Yanming Zhang, M.D.6, Janis Racevckis7*, Hillard M. Lazarus, MD8, Jacob M. Rowe, MB, BS9, Daniel A. Arber, MD10, Matthew J. Wieduwilt, MD11*, Michaela Liedtke, MD12, Julie Bergeron, MD13, Brent L. Wood, MD, PhD14, Yaqi Zhao, MSc15*, Gang Wu, PhD15*, Ti-Cheng Chang15*, Wenchao Zhang15*, Keith W Pratz, MD16,17, Shira N. Dinner, MD18, Noelle V. Frey, MD, MS17, Steven D. Gore, MD19,20, Bhavana Bhatnagar, DO21, Ehab L. Atallah, MD22, Geoffrey L Uy, MD23, Deepa Jeyakumar, MD24, Tara L Lin, MD25, Cheryl L. Willman, MD26*, Daniel J. DeAngelo2, Elad Sharon, MD, MPH27*, Richard F. Little, MD, MPH28, Harry P. Erba, MD, PhD29, Richard M Stone, MD2, Charles G. Mullighan, MBBS, MD5, Mark R. Litzow, MD30 and Martin S. Tallman, MD31

1Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
2Dana-Farber Cancer Institute, Boston, MA
3Carbone Comprehensive Cancer Center, Madison, WI
4Montefiore Medical Ctr. North Div, Bronx, NY
5Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
6Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
7Montefiore Medical Center - Moses Campus, Bronx, NY
8Case Western Reserve University, Cleveland, OH
9Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
10University of Chicago, Chicago, IL
11University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK
12Stanford Cancer Center, Palo Alto, CA
13CEMTL, installation Maisonneuve-Rosemont, Montreal, QC, Canada
14Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
15St. Jude Children's Research Hospital, Memphis, TN
16John Hopkins University, Philadelphia, PA
17Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
18Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
19Division of Cancer Prevention, National Cancer Institute, Rockville, MD
20Yale University, New Haven, CT
21Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
22Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
23Division of Oncology, Washington University School of Medicine, Saint Louis, MO
24Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA
25Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS
26Mayo Clinic, Rochester, MN
27NCI Cancer Therapy Evaluation program (CTEP), Bethesda, MD
28Division of Cancer Prevention, National Cancer Institute, Washington, DC
29University of Alabama At Birmingham, Durham, NC
30Division of Hematology, Mayo Clinic, Rochester, MN
31Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Highland Park, IL

Wei-Ying Jen, MD, FRCPath, MA1*, Elias Jabbour2, Fadi G. Haddad, MD1*, Nicholas J. Short, MD1, Nitin Jain, MD1, Tapan M. Kadia, MD1, Naval Daver, MD1, Gautam Borthakur, MD1, Lewis Nasr1*, Courtney D. DiNardo, MD, MSc1, Marianne Zoghbi1*, Jovitta Jacob, RN3*, Edith Roy3*, Christopher Loiselle, BS3*, Anna Milton3*, Juan Rivera3*, Rebecca Garris1*, Farhad Ravandi, MD, MBBS1 and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX

Changcheng Chen, MD1*, Shuhong Shen, MD, PhD1 and Wenting Hu, MD2*

1Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
2Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology & Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Mojtaba Bakhtiari, MD1*, Travon Baxter, MS2*, Manoj Bhasin, PhD1,3,4,5, Deborah DeRyckere, PhD6 and Swati Bhasin, PhD1,5

1Department of Pediatrics, Emory University, Atlanta, GA
2Pediatrics, Emory University, Atlanta, GA
3Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA
4Department of Biomedical Informatics, Emory University, Atlanta, GA
5Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
6Aflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta, and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA

Prof. Uttam Kumar Nath, MD, DM, Karthik Kumar, MD*, Adamya Gupta, MD*, Reshma Benson, MD* and DR Arjun Kachhwaha, MD, MBBS*

All India Institute of Medical Sciences, Rishikesh, Rishikesh, India

Ahmed Sayed, MBBS1*, Malak Munir, MBBS1*, Sanam Ghazi, MD2*, Mussammat Ferdousi, MD2*, Satyam Krishan, MD3*, Adnan Shaaban, MD2*, Alma Habib, MD4, Onaopepo Kola-Kehinde, BS5*, Patrick Ruz, BS5*, Sarah Khan, BS2*, Sneha Sharma, DO2*, Alexa Mera, MD6*, Narendranath Epperla, MD, MS5 and Daniel Addison, MD7*

1Ain Shams University, Faculty of Medicine, Cairo, Egypt, Cairo, Egypt
2Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, OH, USA, Columbus
3Division of Cardiology, University of Oklahoma Medical Center, Oklahoma City, OK, USA, Oklahoma City
4Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
5The Ohio State University, Columbus, OH
6Division of Rheumatology, The Ohio State University, Columbus, OH, USA, Columbus
7Department of Cardiology, The Ohio State University Wexner Medical Center, Columbus, OH

Leiah J. Brigitha1,2*, Rob Pieters, MD, PhD, MSc1, Marta F. Fiocco, Prof. Dr.1,3,4*, Hester A. de Groot-Kruseman, PhD1*, Marc Bierings, MD5, Cor Van Den Bos, MD, PhD1*, Valerie de Haas, MD, PhD6*, Peter M. Hoogerbrugge, MD, PhD1, Wim J.E. Tissing, MD, PhD7*, Margreet A. Veening, Dr.1* and Inge M. Van Der Sluis, Dr.1

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Pediatric Oncology and Hematology, Erasmus MC–Sophia Children’s Hospital, Rotterdam, Netherlands
3Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands
4Mathematical Instit, Leiden University, Leiden, Netherlands
5Princess Máxima Center, University Hospital for Children, Utrecht, Netherlands
6Princes Máxima Center for Pediatric Oncology, Utrecht, Netherlands
7Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands

*signifies non-member of ASH